Rapid response to a college outbreak of meningococcal serogroup B disease: Nation's first widespread use of bivalent rLP2086 vaccine. Issue 4 (19th May 2017)

• Record Type: Journal Article
• Authors: Fiorito, Theresa M.; Bornschein, Suzanne; Mihalakos, Alysia; Kelleher, Catherine M.; Alexander-Scott, Nicole; Kanadanian, Koren V.; Raymond, Patricia; Sicard, Kenneth; Dennehy, Penelope H.
• Is Part Of: Journal of American college health. Volume 65:Issue 4(2016)
• Page Start: 294
• Page End: 296
• Publication Date: 2017-05-19
• Subjects: Bivalent rLP2086 -- meningococcal B disease -- Neisseria meningitidis -- vaccination; College students -- Health and hygiene -- United States -- Periodicals; College students -- Health and hygiene -- Periodicals; College students -- Mental health -- Periodicals; Universities and colleges -- Health promotion services -- Periodicals; 362.10883781980973
• DOI: 10.1080/07448481.2017.1285772
• Languages: English
• ISSNs: 0744-8481

Abstract

ABSTRACT: Objective : To outline the reasoning behind use of bivalent rLP2086 in a Rhode Island college meningococcal B disease outbreak, highlighting the timeline from outbreak declaration to vaccination clinic, emphasizing that these two time points are <3 days apart.Participants : Staff, faculty, and students at College X eligible for vaccination.Methods : An outbreak response was initiated, advantages/disadvantages of available MenB vaccines were discussed, and a vaccination clinic was coordinated.Results : Bivalent rLP2086 was chosen as the vaccination intervention. We achieved a 94% coverage rate for the first dose. To date, this intervention has prevented further cases of Neisseria meningitidis serogroup B disease at College X.Conclusions : The close, efficient collaboration of public health stakeholders and College X led 94% of the eligible population to be safely vaccinated with at least one dose of bivalent rLP2086. This outbreak marked the first time bivalent rLP2086 was effectively used as an intervention response.